1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Thalamic volumetry and DTI findings from the GM with and without the thalamus, at study entry and after 15 months in healthy controls and patients with PPMSa
Variables Healthy Controls Patients with PPMS P Value NTV Baseline 6.11 (0.48) 4.11 (0.95) <0.001 % Change −1.9 (3.1) −4.7 (6.2) 0.39 Pa n.s. <.0001 Thalamic MD Baseline 0.87 (0.04) 1.08 (0.16) .002 % Change +4.0 (8.7) +2.0 (10.2) .61 Pb n.s. <.0001 Thalamic FA Baseline 0.23 (0.01) 0.21 (0.02) .002 % Change −5.0 (7.1) −12.2 (7.1) .01 Pb n.s. <.0001 GM without thalami MD Baseline 1.02 (0.04) 1.08 (0.06) .005 % Change +1.0 (2.4) +2.0 (6.2) n.s Pb n.s. n.s. GM without thalami FA Baseline 0.15 (0.06) 0.14 (0.11) n.s. % Change −6.1 (12.0) −16.1 (16.1) .06 Pb n.s. .009
a Values are means ± SDs in parentheses.
b Pair-wise comparisons versus baseline values (the text for statistical analysis).